Egypt Showcases its Vision for Developing the Pharmaceutical Sector until 2030 at "Africa Health" Conference
Dr. Ali Al-Ghamrawi, Chairman of the Egyptian Drug Authority, participated in the activities of the fifth edition of the African Medical Exhibition and Conference "Africa Health ExCon 2026." This conference is considered one of the most important medical events on the continent, bringing together senior officials and experts to discuss health challenges and the development of medical services in Africa.
During his speech, Dr. Al-Ghamrawi reviewed the significant achievements recently made by the pharmaceutical sector in Egypt. He explained that the state is currently working on implementing a comprehensive development plan extending until 2030. This plan aims to increase local pharmaceutical production, ensure international quality standards, and provide medicines at affordable prices for Egyptian citizens.
The Chairman of the Drug Authority also pointed out the importance of enhancing cooperation among African countries in the medical field. He emphasized that Egypt seeks to be a leading regional hub in the pharmaceutical industry by exporting Egyptian medical products and transferring technical expertise to neighboring countries. This cooperation helps achieve pharmaceutical security for the entire continent.
In conclusion, Dr. Al-Ghamrawi affirmed that developing the pharmaceutical sector is not merely an economic goal, but rather a fundamental part of Egypt's vision to improve public health. He stressed that the Authority continues to support innovation and scientific research to achieve the best health outcomes by 2030, thereby enhancing Egypt's position in the global medical market.